HeartSciences (HSCS) Cash from Investing Activities (2022 - 2025)
HeartSciences' (HSCS) quarterly Cash from Investing Activities came in at -$15770.0 in Q4 2025, down 169.94% YoY from $22547.3 in Q4 2024, and down 1837.35% on a QoQ basis from -$814.0 in Q3 2025.
HeartSciences (HSCS) Cash from Investing Activities (2022 - 2025) Analysis & Trends
HeartSciences (HSCS) has 4 years of Cash from Investing Activities data on file, last reported at -$15770.0 in Q4 2025.
- Quarterly Cash from Investing Activities fell 169.94% year-over-year to -$15770.0 in Q4 2025, while the trailing twelve-month figure through Apr 2026 was -$24396.0 (up 19.19% YoY) and the FY2026 annual result came in at -$44452.0, down 47.25% from the prior year.
- Cash from Investing Activities declined to -$15770.0 in Q4 2025, from -$814.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$814.0 in Q3 2025 to a low of -$69228.0 in Q2 2024.
- A 4-year average of -$14642.4 and a median of -$7247.0 in 2022 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities slumped 1317.73% — and 2025, when it jumped 88.72%.
- Tracing HSCS's Cash from Investing Activities over 4 years: stood at -$7247.0 in 2022, then soared by 73.06% to -$1952.0 in 2023, then tumbled by 199.28% to -$5842.0 in 2024, then tumbled by 169.94% to -$15770.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$15770.0 (Q4 2025), -$814.0 (Q3 2025), and -$7812.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | HeartSciences | 6.54 Mn | 4.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -15,770.00 |
| Oct 31, 2025 | -15,770.00 |
| Jul 31, 2025 | -814.00 |
| Jul 31, 2025 | -814.00 |
| Apr 30, 2025 | -7,812.00 |
| Apr 30, 2025 | -7,812.00 |
| Jan 31, 2025 | -15,701.00 |
| Jan 31, 2025 | -15,701.00 |
| Oct 31, 2024 | -5,842.00 |
| Oct 31, 2024 | -5,842.00 |
| Jul 31, 2024 | -833.00 |
| Jul 31, 2024 | -833.00 |
| Apr 30, 2024 | -69,228.00 |
| Apr 30, 2024 | -69,228.00 |
| Jan 31, 2024 | -49,181.00 |
| Jan 31, 2024 | -49,181.00 |
| Oct 31, 2023 | -1,952.00 |
| Oct 31, 2023 | -1,952.00 |
| Jul 31, 2023 | -4,910.00 |
| Jul 31, 2023 | -4,910.00 |